CTRI/2017/12/010862招募中4 期
TWO DOSES OF MIFEPRISTONE FOLLOWED BY MISOPROSTOL FOR MEDICAL TERMINATION OF PREGNANCY IN THE SECOND TRIMESTER - Two dose Mife regimen for 2nd trimester MTP
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- PGIMER
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •A total number of 100 women admitted for MTP in 2nd trimester (13-20 weeks) will be recruited provided they fulfil the following inclusion and exclusion criteria:
- •Inclusion Criteria:
- •1.Age >=18 yrs to 45 years and a singleton intrauterine viable pregnancy
- •2.Gestational age 13-20 weeks
- •3.Women fulfilling the pre-requisites of Indian MTP Act, 1972
排除标准
- •Exclusion Criteria:
- •1.Having either taken MTP Pill from outside or self prescribed or incomplete abortion
- •2.Prior two or more uterine surgeries (caesarean / myomectomy)
- •3.Moderate or severe anaemia (Haemoglobin <8 gm /dL)
- •4.Heart disease, uncontrolled hypertension ( >140/90 mm hg) bronchial asthma, coagulation disorder and any other medical illness
- •5.Known hypersensitivity to mifepristone or misoprostol
- •6.Haemodynamically unstable at the time of presentation
- •7.Contra-indications to the use of mifepristone or misoprostol: ectopic pregnancy, inherited porphyria, chronic adrenal failure, on immunosuppressants (corticosteroids).
研究者
相似试验
尚未招募
Unknown
Medications used to induce laborCTRI/2023/10/058260Dr Asmita Yadav
招募中
不适用
COMPARISON OF TWO DRUG REGIMEN FOR TREATMENT OF EARLY PREGNANCY FAILURECTRI/2013/03/003492niversity College of Medical Sciences and Guru Teg Bahadur Hospital92
招募中
3 期
Medicines for abortion between 10-20 weeksCTRI/2016/06/006980Concept foundation670
进行中（未招募）
1 期
Repeated doses of misoprostol for medical treatment of intact miscarriageIntact miscarriage which has not been expelled from the body (missed abortion)EUCTR2011-001505-26-SEKarolinska Institutet899,991
已完成
不适用
Misoprostol administered sublingually for second trimester pregnancy terminatioAbortionInduced abortionPregnancy and ChildbirthISRCTN72965671DP/UNFPA/WHO/World Bank - Special Programme of Research, Development and Research Training in Human Reproduction680